Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Sales force

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Aug 10, 2022 8:36pm

202 Views

Post# 34886920

RE:RE:Sales force

Check out this job at Theratechnologies Inc.:
https://www.linkedin.com/jobs/view/3213659632

SPCEO1 wrote: He also talked about having his own Salesforce gave him the confidence to get another drug to sell, which would help TH reach the sales targets needed to access tranche 3, and particularly tranche 4, of the debt deal with Marathon. He should try to find another Trogarzo type deal where not much capital is involved in acquiring new sales.

BlitzBuuckeyeoh wrote: Paul seems very excited about having our own and the possibilities of adding products and leveraging our contacts.